Nautilus is a biotechnology company who is developing a proteomics platform enabling a dramatic acceleration of basic science research, significantly improving the success rate of therapeutic development, and enhancing opportunities for personalized and predictive medicine.
NAUT
2.51 as of 3/24/23
